Cerity Partners LLC Increases Stock Position in Haleon plc (NYSE:HLN)

Cerity Partners LLC lifted its holdings in shares of Haleon plc (NYSE:HLN - Free Report) by 312.6% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 152,235 shares of the company's stock after acquiring an additional 115,342 shares during the period. Cerity Partners LLC's holdings in Haleon were worth $1,253,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of HLN. FMR LLC lifted its holdings in shares of Haleon by 22.2% during the third quarter. FMR LLC now owns 53,951,936 shares of the company's stock worth $449,420,000 after purchasing an additional 9,812,040 shares during the period. Wellington Management Group LLP acquired a new position in Haleon during the third quarter valued at $42,640,000. Envestnet Asset Management Inc. boosted its holdings in Haleon by 121.2% in the third quarter. Envestnet Asset Management Inc. now owns 5,931,187 shares of the company's stock valued at $49,407,000 after purchasing an additional 3,249,517 shares during the last quarter. Cambiar Investors LLC acquired a new stake in Haleon during the 4th quarter worth about $15,225,000. Finally, Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of Haleon by 6,593.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,692,937 shares of the company's stock valued at $14,102,000 after buying an additional 1,667,643 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Price Performance

HLN traded up $0.12 during midday trading on Monday, hitting $8.35. 3,991,274 shares of the company traded hands, compared to its average volume of 5,500,084. The business has a 50 day simple moving average of $8.30 and a two-hundred day simple moving average of $8.29. Haleon plc has a 52-week low of $7.70 and a 52-week high of $8.99. The company has a market capitalization of $38.10 billion, a price-to-earnings ratio of 29.80, a PEG ratio of 2.15 and a beta of 0.29. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53.

Haleon Dividend Announcement

The business also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be paid a $0.1064 dividend. This represents a yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 14th. Haleon's dividend payout ratio is presently 75.00%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on HLN shares. Argus reiterated a "buy" rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC initiated coverage on shares of Haleon in a research report on Wednesday, April 17th. They set a "buy" rating on the stock. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy".

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.